Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-fiber nociceptor terminals are the unmyelinated peripheral endings of primary afferent neurons that specialize in detecting noxious stimuli, including thermal, mechanical, and chemical insults (StatPearls, 2023). These terminals are characterized by a slow conduction velocity and the expression of various specialized receptors and ion channels, such as Transient Receptor Potential (TRP) channels and voltage-gated sodium channels like Nav1.7 and Nav1.8 (Nature Reviews Neurology, 2013). In pathological states, these terminals can become hypersensitized, contributing to chronic and neuropathic pain conditions (NIH, 2021). Therapeutic strategies often target these terminals to provide localized analgesia, either by blocking signal transmission with local anesthetics or by desensitizing the terminals through prolonged activation of TRPV1 receptors (PubMed, 2017). Because they are the primary site of pain initiation, they represent a critical focus for the development of topical and regional pain management therapies (Journal of Pain Research, 2018). Drugs like capsaicin work by initially stimulating and then exhausting these terminals, leading to a period of reduced sensitivity known as defunctionalization (British Journal of Anaesthesia, 2011). Local anesthetics like lidocaine block the sodium channels within these terminals to prevent the propagation of pain signals to the central nervous system (StatPearls, 2023). Monitoring the density of these terminals in the skin via intraepidermal nerve fiber density (IENFD) is a common clinical method for diagnosing small fiber neuropathies (Neurology, 2010).
Modulation of ion channel activity (e.g., TRPV1, Nav1.7) to inhibit action potential generation or induce temporary terminal defunctionalization.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-fiber nociceptor terminal.